DC Chemicals' products qualify for U.S. tariff exemptions. We guarantee no price increases due to customs duties and maintain stable supply, continuing to deliver reliable research solutions to our American clients.
| Cas No.: | 125697-91-8 |
| Chemical Name: | Benzoic acid,5-[bis[(2-hydroxyphenyl)methyl]amino]-2-hydroxy- |
| Synonyms: | Benzoic acid,5-[bis[(2-hydroxyphenyl)methyl]amino]-2-hydroxy-;Lavendustin B;5-[bis[(2-hydroxyphenyl)methyl]amino]-2-hydroxybenzoic acid;N,N-BIS(2'-HYDROXYBENZYL)-3-AMINOSALICYLIC ACID;5-AMINO-(N,N'-BIS-2-HYDROXYBENZYL)SALICYLIC ACID;2-Hydroxy-5-[bis(2-hydroxybenzyl)amino]benzoic acid;5-[Bis[(2-hydroxyphenyl)Methyl]aMino]-2-hydroxy-benzoic Acid |
| SMILES: | OC1C=CC=CC=1CN(CC1C=CC=CC=1O)C1=CC(C(O)=O)=C(O)C=C1 |
| Formula: | C21NO5H19 |
| M.Wt: | 365.3793 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | Lavendustin B is an inhibitor of HIV-1 integrase interaction with LEDGF/p75 with an IC50 of 94.07 μM. Lavendustin B is an ATP-competitive GLUT1 inhibitor with a Ki of 15 µM. Lavendustin B is also a weak inhibitor of tyrosine kinases[1][2]. |
| In Vitro: | In HL-60 cells, Lavendustin B (0-1000 µM) inhibits the uptake of methylglucose, deoxyglucose, and dehydroascorbic acid in human erythrocytes in a dose-dependent manner, with 50% inhibition observed at approximately 10-30 µM. Moreover, increasing concentrations of Lavendustin B inhibited, in a dose-dependent manner, the binding of cytochalasin B to human erythrocyte membranes[1]. |
| References: | [1]. J C Vera, et al. Direct inhibition of the hexose transporter GLUT1 by tyrosine kinase inhibitors. Biochemistry. 2001 Jan 23;40(3):777-90. [2]. Fatima E Agharbaoui, et al. Computational and synthetic approaches for developing Lavendustin B derivatives as allosteric inhibitors of HIV-1 integrase. Eur J Med Chem. 2016 Nov 10;123:673-683. |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|
| 2018-0101 |
|